Functional polymorphisms in the promoter regions of MMP2 and MMP3 are not associated with melanoma progression

Journal of Negative Results in BioMedicine

Volumn 6, Issue , 2007, Pages

  Cotignola, Javier ^a   Roy, Pampa ^a   Patel, Ami ^a   Ishill, Nicole ^a   Shah, Shivang ^a   Houghton, Alan ^a   Coit, Daniel ^a   Halpern, Allan ^a   Busam, Klaus ^a   Berwick, Marianne ^b   Orlow, Irene ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; STROMELYSIN; MMP2 PROTEIN, HUMAN; MMP3 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER PATIENT; CANCER RISK; CHI SQUARE TEST; CHILD; CORRELATION COEFFICIENT; FEMALE; FISHER EXACT TEST; GENE SEQUENCE; GENETIC POLYMORPHISM; GENOTYPE; GERM LINE; HETEROZYGOTE; HUMAN; HUMAN CELL; KAPLAN MEIER METHOD; LENTIGO; LOG RANK TEST; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; MELTING POINT; METASTASIS; MULTIVARIATE ANALYSIS; NEVUS; PATHOLOGY; PHENOTYPE; POLYMERASE CHAIN REACTION; PROMOTER REGION; RACE; SAMPLE; SEX; SURVIVAL; DISEASE COURSE; ENZYMOLOGY; GENETICS; MIDDLE AGED; PRESCHOOL CHILD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 3; MELANOMA; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS);

EID: 37349121769     PISSN: None     EISSN: 14775751     Source Type: Journal    
DOI: 10.1186/1477-5751-6-9     Document Type: Article

References (19)

1. Matrix metalloproteinases: they're not just for matrix anymore! LJ McCawley LM Matrisian, Curr Opin Cell Biol 2001 13 534 540 10.1016/S0955- 0674(00)00248-9 11544020
2. Matrix metalloproteinases in human melanoma. UB Hofmann JR Westphal GN Van Muijen DJ Ruiter, J Invest Dermatol 2000 115 337 344 10.1046/j.1523-1747. 2000.00068.x 10951266
3. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression. UB Hofmann JR Westphal AJ Zendman JC Becker DJ Ruiter GN van Muijen, J Pathol 2000 191 245 256 10.1002/1096-9896(2000)9999: 9999<::AID-PATH632>3.0.CO;2-# 10878545
4. Matrix metalloproteinase-2 (72 kD type IV collagenase) expression occurs in the early stage of human melanocytic tumour progression and may have prognostic value. A Vaisanen H Tuominen M Kallioinen T Turpeenniemi-Hujanen, J Pathol 1996 180 283 289 10.1002/(SICI)1096-9896(199611)180:3<283::AID- PATH662>3.0.CO;2-3 8958806
5. Control of melanoma progression by various matrikines from basement membrane macromolecules. S Pasco L Ramont FX Maquart JC Monboisse, Crit Rev Oncol Hematol 2004 49 221 233 10.1016/j.critrevonc.2003.09.006 15036262
6. Matrix metalloproteinase expression in malignant melanomas: tumor-extracellular matrix interactions in invasion and metastasis. B Bodey B Bodey Jr SE Siegel HE Kaiser, In Vivo 2001 15 57 64 11286131
7. High expression levels of collagenase-1 and stromelysin-1 correlate with shorter disease-free survival in human metastatic melanoma. J Nikkola P Vihinen T Vlaykova M Hahka-Kemppinen VM Kahari S Pyrhonen, Int J Cancer 2002 97 432 438 10.1002/ijc.1636 11802203
8. Immunohistochemical expression of vascular endothelial growth factor, matrix metalloproteinase 2, and matrix metalloproteinase 9 in cutaneous melanocytic lesions. O Simonetti G Lucarini D Brancorsini P Nita ML Bernardini G Biagini A Offidani, Cancer 2002 95 1963 1970 10.1002/cncr.10888 12404291
9. Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele-specific transcriptional regulation. SJ Price DR Greaves H Watkins, J Biol Chem 2001 276 7549 7558 10.1074/jbc.M010242200 11114309
10. Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression. S Ye P Eriksson A Hamsten M Kurkinen SE Humphries AM Henney, J Biol Chem 1996 271 13055 13060 10.1074/jbc.271.22.13055 8662692
11. Functional haplotypes in the promoter of matrix metalloproteinase-2 predict risk of the occurrence and metastasis of esophageal cancer. C Yu Y Zhou X Miao P Xiong W Tan D Lin, Cancer Res 2004 64 7622 7628 10.1158/0008-5472.CAN- 04-1521 15492291
12. University of California Santa Cruz (UCSC) Genome Browser Database. http://genome.ucsc.edu/
13. National Center for Biotechnology Information (NCBI). http://www.ncbi.nlm.nih.gov/
14. A single nucleotide polymorphism in the matrix metalloproteinase-3 promoter enhances breast cancer susceptibility. G Ghilardi ML Biondi M Caputo S Leviti M DeMonti E Guagnellini R Scorza, Clin Cancer Res 2002 8 3820 3823 12473595
15. Genotypes and haplotypes of matrix metalloproteinase 1, 3 and 12 genes and the risk of lung cancer. L Su W Zhou K Asomaning X Lin JC Wain TJ Lynch G Liu DC Christiani, Carcinogenesis 2006 27 1024 1029 10.1093/carcin/bgi283 16311244
16. No association between the C-1562T polymorphism in the promoter of matrix metalloproteinase-9 gene and non-small cell lung carcinoma. Y Wang S Fang L Wei R Wang X Jin D Wen Y Li W Guo N Wang J Zhang, Lung Cancer 2005 49 155 161 10.1016/j.lungcan.2005.04.006 15949868
17. Polymorphisms in nucleotide excision repair genes and risk of multiple primary melanoma: the Genes Environment and Melanoma Study. RC Millikan A Hummer C Begg J Player AR de Cotret S Winkel H Mohrenweiser N Thomas B Armstrong A Kricker, Carcinogenesis 2006 27 610 618 10.1093/carcin/bgi252 16258177
18. Prognostic significance of MMP-1 and MMP-3 functional promoter polymorphisms in colorectal cancer. F Zinzindohoue T Lecomte JM Ferraz AM Houllier PH Cugnenc A Berger H Blons P Laurent-Puig, Clin Cancer Res 2005 11 594 599 15701845
19. The LightTyper: high-throughput genotyping using fluorescent melting curve analysis. CD Bennett MN Campbell CJ Cook DJ Eyre LM Nay DR Nielsen RP Rasmussen PS Bernard, Biotechniques 2003 34 1288 1292 1294-1285 12813898